{"gene":"DARS2","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2014,"finding":"DARS2 (mitochondrial aspartyl-tRNA synthetase) is required for mitochondrial protein synthesis; its loss in heart and skeletal muscle leads to severe respiratory chain deficiency, but stress responses (including FGF21 mitokine induction) are activated in a tissue-specific manner in cardiomyocytes independently of respiratory chain deficiency, demonstrating that mitochondrial proteostasis impairment is sensed as a distinct signal.","method":"Conditional cardiac/skeletal muscle Dars2 knockout mice; respiratory chain complex assays; FGF21 expression analysis; mitochondrial protein synthesis measurements","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 2 — clean tissue-specific KO with multiple orthogonal readouts (RC assays, protein synthesis, FGF21 signaling), replicated across two tissues","pmids":["24606902"],"is_preprint":false},{"year":2012,"finding":"Cell-type-specific splicing of DARS2 mRNA determines vulnerability in LBSL: intronic mutations affecting exon 3 splicing have a larger effect on exon 3 exclusion in neural (especially neuronal) cell lines than in non-neural cells, and baseline inclusion of exon 3 is less efficient in neural cells, explaining selective white matter tract involvement.","method":"Splicing reporter construct transfected into neural vs. non-neural cell lines; quantitative RT-PCR of exon inclusion","journal":"The Biochemical Journal","confidence":"High","confidence_rationale":"Tier 2 — functional splicing reporter assay across multiple cell types with clear mechanistic outcome","pmids":["22023289"],"is_preprint":false},{"year":2017,"finding":"Loss of DARS2 in forebrain-hippocampal neurons causes strong mitochondrial dysfunction and progressive neuronal cell death, whereas myelin-producing cells are resistant to cell death despite robust respiratory chain deficiency, indicating that neuronal/axonal loss is the primary defect in LBSL; neuroinflammation is activated early in disease progression.","method":"Conditional Dars2 knockout in forebrain neurons (CamKII-Cre) and oligodendrocytes; respiratory chain assays; histopathology; immunostaining for neuroinflammation markers","journal":"Human Molecular Genetics","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with defined cellular phenotype and mechanistic distinction between cell types","pmids":["28985337"],"is_preprint":false},{"year":2020,"finding":"DARS2 is indispensable for Purkinje cell survival; conditional Purkinje cell-specific Dars2 deletion causes severe mitochondrial dysfunction, massive Purkinje cell loss by 15 weeks, rapid motor skill deterioration, and prominent neuroinflammation.","method":"Purkinje cell-specific conditional Dars2 knockout mice (Pcp2-Cre); mitochondrial function assays; histopathology; behavioral motor testing; immunostaining for neuroinflammation","journal":"Human Molecular Genetics","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with multiple functional and histological readouts","pmids":["32766765"],"is_preprint":false},{"year":2019,"finding":"Dars2 disruption in CamKIIα-expressing cortical and hippocampal neurons leads to progressive brain atrophy, reduced corpus callosum thickness, behavioral dysfunction, and microglial neuroinflammation; RNA-seq shows immune/cytokine pathway activation precedes the overt behavioral phenotype.","method":"CamKIIα-Cre conditional Dars2 knockout mice; RNAseq gene expression; behavioral assays; MRI; microglial morphology analysis","journal":"Experimental Neurology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with transcriptomic and behavioral/histological phenotyping across timepoints","pmids":["31887305"],"is_preprint":false},{"year":2021,"finding":"DARS2 encodes a mitochondrial aspartyl-tRNA synthetase homodimer; missense variants that hit regions involved in tRNA-Asp binding, aspartyl-adenosine-5'-monophosphate binding, and/or homodimerization abolish mitochondrial function when expressed in the yeast DARS2 ortholog (MSD1), establishing structure-function relationships for catalytic and dimerization domains.","method":"Structural analysis of variant positions; functional complementation in msd1Δ yeast (oxidative growth assay)","journal":"Neurology. Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — yeast functional complementation plus structural analysis, single study","pmids":["33977142"],"is_preprint":false},{"year":2022,"finding":"Specific DARS2 missense variants (p.Glu158Val; p.Glu277Lys) differentially impair mitochondrial aspartyl-tRNA synthetase function: p.Glu277Lys (equivalent to yeast p.Glu259Lys) causes complete loss of oxidative growth and oxygen consumption, while p.Glu158Val (equivalent to yeast p.Gln137Val) causes significant but partial loss; structural analysis indicates p.Glu158Val interferes with tRNA-Asp binding and p.Glu277Lys impacts homodimerization and catalysis.","method":"Yeast msd1Δ complementation assay (oxidative growth, oxygen consumption); in silico structural modeling","journal":"Molecular Genetics and Metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — functional yeast assay with multiple variants and structural analysis, single lab","pmids":["35820270"],"is_preprint":false},{"year":2025,"finding":"DARS2 promotes bladder cancer cell cycle progression (G1-to-S transition) by upregulating CDK4 expression, suppressing cellular senescence, and enhancing PINK1-mediated mitophagy; both in vitro and in vivo experiments confirmed DARS2 inhibits senescence and drives tumor progression through this mitophagy pathway.","method":"siRNA knockdown and overexpression in bladder cancer cells; xenograft mouse models; flow cytometry cell cycle analysis; CDK4/PINK1 Western blot; mitophagy assays","journal":"International Journal of Biological Sciences","confidence":"Medium","confidence_rationale":"Tier 2 — KO/OE with defined molecular pathway (CDK4, PINK1-mitophagy) validated in vitro and in vivo, single lab","pmids":["39990673"],"is_preprint":false},{"year":2023,"finding":"DARS2 mutations in LBSL patient iPSC-derived cerebral organoids cause global dysregulation of mRNA metabolism and splicing, including dysregulated RNA splicing and protein translation pathways; DARS2 protein is downregulated in iPSC-derived neurons due to increased exon 3 exclusion, and LBSL neurons show growth defects under live cell imaging, suggesting DARS2 may have roles beyond canonical aminoacylation.","method":"SMART-seq2 single-cell RNA sequencing of patient iPSC-derived cerebral organoids; iPSC-derived neurons via Neurogenin 2 overexpression; live cell imaging of neuronal growth; exon 3 splicing analysis; Western blot for DARS2 protein","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — multi-modal analysis in patient-derived organoids and neurons, single lab with orthogonal methods","pmids":["37563224"],"is_preprint":false},{"year":2025,"finding":"DARS2 is secreted from airway epithelial cells in response to TNFα stimulation in a TNF-receptor 1-dependent manner via the endosomal sorting complex required for extracellular transport; secreted DARS2 binds to macrophages, is internalized, and induces an M1-like phenotype in recipient macrophages, establishing a paracrine cytokine-modulatory role for mitochondrial DARS2.","method":"BEAS-2B cell secretion assays; adoptive media transfer to THP1 macrophages; blocking antibodies against TNFR1; siRNA knockdown; chemical inhibitors of endosomal sorting; macrophage polarization readouts","journal":"Physiological Reports","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic secretion and paracrine signaling study with multiple inhibitor approaches, single lab","pmids":["41214844"],"is_preprint":false},{"year":2025,"finding":"A p.Pro503Leu DARS2 variant reduces enzymatic (aminoacylation) activity by 75% in HEK293 cells; hypomorphic variant p.Ser238Phe paired with more deleterious alleles results in axonal CMT without leukoencephalopathy, establishing a genotype-severity continuum for DARS2-associated diseases; functional studies in fibroblasts showed reduced DARS2 protein, mitochondrial network abnormalities, and impaired mitochondrial function.","method":"Enzymatic activity assay in HEK293 cells; fibroblast functional studies (DARS2 protein levels, mitochondrial network imaging, mitochondrial function assays)","journal":"Annals of Neurology","confidence":"Medium","confidence_rationale":"Tier 2 — direct enzymatic activity assay plus fibroblast functional studies, multiple variants and families","pmids":["40814755"],"is_preprint":false},{"year":2025,"finding":"AAV9-mediated DARS2 gene supplementation in LBSL patient iPSC-derived neurons increases DARS2 expression, improves mitochondrial function, promotes axonal growth, and reduces lactate release; in CamKIIα-Cre Dars2 knockout mice, intracerebroventricular AAV9-DARS2 injection improves behavior and reduces cortical neurodegeneration at 6 months, providing proof-of-concept for gene therapy.","method":"AAV9 gene delivery in patient iPSC-derived neurons (mitochondrial function, axonal growth, lactate assays); intracerebroventricular injection in Dars2 conditional KO mice (behavioral testing, histopathology)","journal":"Annals of Neurology","confidence":"Medium","confidence_rationale":"Tier 2 — gene rescue in both patient cell model and mouse KO, multiple functional readouts, single study","pmids":["40948401"],"is_preprint":false},{"year":2025,"finding":"ALA/Fe (aminolevulinate plus ferrous iron) treatment rescues marked mitochondrial and antioxidant deficiencies in DARS2-deficient fibroblasts from LBSL patients via Nrf-2-mediated cytoprotection; dexamethasone (Nrf-2 inhibitor) blocks these positive effects, identifying Nrf-2 pathway activation as a therapeutic mechanism.","method":"LBSL patient fibroblasts treated with ALA/Fe; mitochondrial function and antioxidant assays; Nrf-2 pathway inhibition with dexamethasone","journal":"Biochimica et Biophysica Acta. Molecular Basis of Disease","confidence":"Low","confidence_rationale":"Tier 3 — pharmacological rescue in patient fibroblasts, single lab, mechanistic link inferred from inhibitor experiment","pmids":["40185339"],"is_preprint":false}],"current_model":"DARS2 encodes mitochondrial aspartyl-tRNA synthetase, a homodimeric enzyme that catalyzes the aminoacylation of mitochondrial tRNA-Asp (required for mitochondrial protein synthesis); loss of DARS2 impairs mitochondrial translation and respiratory chain function in a tissue- and cell-type-specific manner, with neurons (especially Purkinje cells and cortical neurons) being particularly vulnerable to DARS2 depletion-induced mitochondrial dysfunction and death while oligodendrocytes are relatively resistant, and DARS2 additionally functions outside mitochondria as a TNFα-inducible secreted factor that modulates macrophage polarization, and within cancer cells promotes cell cycle progression via CDK4 and PINK1-mediated mitophagy."},"narrative":{"teleology":[{"year":2012,"claim":"Resolving why DARS2 mutations selectively damage the nervous system despite ubiquitous expression, this study showed that cell-type-specific splicing efficiency of DARS2 exon 3 is intrinsically lower in neural cells, so intronic LBSL mutations cause disproportionate exon skipping and protein loss in the most vulnerable tissue.","evidence":"Splicing reporter constructs transfected into neural vs. non-neural cell lines with quantitative RT-PCR readout","pmids":["22023289"],"confidence":"High","gaps":["Trans-acting splicing factors responsible for differential exon 3 inclusion are not identified","Splicing was measured in cell lines, not primary human neurons or oligodendrocytes in vivo"]},{"year":2014,"claim":"Establishing the core enzymatic requirement, conditional Dars2 knockout in heart and skeletal muscle demonstrated that DARS2 is essential for mitochondrial protein synthesis and respiratory chain assembly, and revealed that mitochondrial proteostasis stress signals (e.g., FGF21 induction) are activated independently of respiratory chain deficiency.","evidence":"Conditional cardiac/skeletal muscle Dars2 knockout mice with respiratory chain assays, mitochondrial translation measurements, and FGF21 expression analysis","pmids":["24606902"],"confidence":"High","gaps":["Whether the same proteostasis stress responses occur in neurons was not tested","Downstream signaling pathways connecting mitochondrial proteostasis sensing to FGF21 induction were not fully delineated"]},{"year":2017,"claim":"Demonstrating that neuronal death—not demyelination—is the primary driver of LBSL pathology, cell-type-specific Dars2 ablation showed that forebrain neurons die progressively from mitochondrial dysfunction while oligodendrocytes survive despite equivalent respiratory chain deficiency.","evidence":"CamKII-Cre and oligodendrocyte-Cre conditional Dars2 knockout mice with respiratory chain assays, histopathology, and neuroinflammation markers","pmids":["28985337"],"confidence":"High","gaps":["Molecular basis for oligodendrocyte resistance to DARS2 loss remains unknown","Whether secondary demyelination contributes to disease progression independently of neuronal loss is unclear"]},{"year":2019,"claim":"Extending the neuronal phenotype, Dars2 loss in cortical and hippocampal neurons was shown to cause progressive brain atrophy, corpus callosum thinning, and behavioral deficits, with transcriptomic evidence that microglial neuroinflammation precedes overt neurodegeneration.","evidence":"CamKIIα-Cre conditional Dars2 knockout mice with RNA-seq, behavioral assays, MRI, and microglial morphology analysis","pmids":["31887305"],"confidence":"High","gaps":["Causal contribution of neuroinflammation versus intrinsic neuronal death to disease progression not dissected","Whether anti-inflammatory intervention can slow neurodegeneration was not tested"]},{"year":2020,"claim":"Purkinje cells were shown to be exquisitely dependent on DARS2, with cell-specific deletion causing near-complete Purkinje cell loss by 15 weeks and rapid cerebellar ataxia, consistent with the prominent cerebellar phenotype in LBSL patients.","evidence":"Pcp2-Cre Purkinje cell-specific Dars2 knockout mice with mitochondrial function assays, histopathology, and motor behavioral testing","pmids":["32766765"],"confidence":"High","gaps":["Whether Purkinje cell vulnerability reflects higher mitochondrial translation demand or lower compensatory capacity is unresolved","Non-cell-autonomous effects on other cerebellar neurons not characterized"]},{"year":2021,"claim":"Structure–function relationships were established for DARS2: the enzyme functions as a homodimer, and missense variants disrupting tRNA-Asp binding, aminoacyl-adenylate binding, or the dimerization interface abolish mitochondrial function.","evidence":"Structural analysis of variant positions with functional complementation in yeast msd1Δ (oxidative growth assay)","pmids":["33977142"],"confidence":"Medium","gaps":["No crystal structure of human DARS2 is available; structural inferences are based on homology models","Aminoacylation kinetics for individual variants not measured in a purified system"]},{"year":2022,"claim":"Genotype–severity correlations were refined: the p.Glu277Lys variant (affecting dimerization/catalysis) completely ablates function whereas p.Glu158Val (affecting tRNA binding) causes partial loss, demonstrating that different domains contribute unequally to catalytic activity.","evidence":"Yeast msd1Δ complementation with oxidative growth and oxygen consumption measurements plus in silico structural modeling","pmids":["35820270"],"confidence":"Medium","gaps":["Human DARS2 enzymatic activity for these variants not measured directly","Whether partial loss variants permit residual mitochondrial translation in human neurons is untested"]},{"year":2023,"claim":"Patient iPSC-derived cerebral organoids revealed that DARS2 deficiency causes broad mRNA metabolism and splicing dysregulation beyond simple aminoacylation loss, with LBSL neurons showing growth defects, suggesting non-canonical DARS2 roles.","evidence":"SMART-seq2 single-cell RNA-seq of LBSL patient iPSC-derived organoids; live cell imaging of iPSC-derived neurons; exon 3 splicing and protein analysis","pmids":["37563224"],"confidence":"Medium","gaps":["Whether RNA metabolism changes are direct or secondary to mitochondrial dysfunction is unresolved","Non-canonical DARS2 functions have not been biochemically defined"]},{"year":2025,"claim":"Multiple independent advances in 2025 expanded DARS2 biology in three directions: (1) a genotype-severity continuum was demonstrated, with hypomorphic variants causing axonal CMT without leukoencephalopathy; (2) AAV9-mediated DARS2 gene supplementation rescued neuronal mitochondrial function and neurodegeneration in both patient cells and knockout mice; and (3) DARS2 was found to have extramitochondrial functions—as a TNFα-induced secreted factor driving M1 macrophage polarization and as a bladder cancer cell cycle promoter via CDK4/PINK1-mitophagy.","evidence":"Enzymatic activity assays in HEK293 cells and patient fibroblasts (PMID:40814755); AAV9 gene delivery in iPSC neurons and intracerebroventricular injection in Dars2 KO mice (PMID:40948401); airway epithelial cell secretion assays with macrophage polarization readouts (PMID:41214844); siRNA/overexpression in bladder cancer cells with xenograft validation (PMID:39990673)","pmids":["40814755","40948401","41214844","39990673"],"confidence":"Medium","gaps":["AAV9 gene therapy long-term efficacy and optimal dosing not established","Mechanism by which DARS2 exits mitochondria for secretion is not defined","CDK4/PINK1-mitophagy link to DARS2 in cancer awaits independent replication","Whether the secreted DARS2 paracrine function is relevant in the CNS is unknown"]},{"year":null,"claim":"Key unresolved questions include the molecular basis for differential neuronal versus glial vulnerability to DARS2 loss, whether non-canonical (extra-mitochondrial) DARS2 functions contribute to LBSL pathogenesis, and whether gene therapy can achieve durable clinical benefit in patients.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of human DARS2 is available","Direct aminoacylation kinetics for disease-associated variants have not been measured with purified human enzyme","Mechanism connecting DARS2 loss to the mRNA splicing dysregulation observed in organoids is unknown","Contribution of neuroinflammation as a therapeutic target in LBSL is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,5,6,10]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,6,10]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,3,5]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,5,6,10]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,2,3,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9]}],"complexes":["DARS2 homodimer"],"partners":["CDK4","PINK1","TNFRSF1A"],"other_free_text":[]},"mechanistic_narrative":"DARS2 encodes the mitochondrial aspartyl-tRNA synthetase, a homodimeric enzyme that aminoacylates mitochondrial tRNA-Asp and is therefore essential for mitochondrial translation and respiratory chain function [PMID:24606902, PMID:33977142]. Loss of DARS2 causes severe, cell-type-specific vulnerability: neurons—particularly Purkinje cells and cortical/hippocampal neurons—undergo progressive mitochondrial dysfunction, neuroinflammation, and cell death, whereas oligodendrocytes tolerate respiratory chain deficiency, explaining the predominantly neuronal pathology in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a disease caused by biallelic DARS2 mutations whose severity follows a genotype-dependent continuum extending to axonal Charcot-Marie-Tooth neuropathy [PMID:28985337, PMID:32766765, PMID:22023289, PMID:40814755]. Cell-type-specific differences in DARS2 exon 3 splicing efficiency govern the degree of residual functional protein in neural versus non-neural cells, providing a molecular basis for selective CNS vulnerability [PMID:22023289, PMID:37563224]. Beyond its canonical mitochondrial aminoacylation role, DARS2 is secreted from epithelial cells in a TNFα/TNFR1-dependent manner and promotes M1-like macrophage polarization, and in cancer cells it drives G1-to-S cell cycle progression via CDK4 upregulation and PINK1-mediated mitophagy [PMID:41214844, PMID:39990673]."},"prefetch_data":{"uniprot":{"accession":"Q6PI48","full_name":"Aspartate--tRNA ligase, mitochondrial","aliases":["Aspartyl-tRNA synthetase","AspRS"],"length_aa":645,"mass_kda":73.6,"function":"Catalyzes the attachment of aspartate to tRNA(Asp) in a two-step reaction: aspartate is first activated by ATP to form Asp-AMP and then transferred to the acceptor end of tRNA(Asp)","subcellular_location":"Mitochondrion matrix; Mitochondrion membrane","url":"https://www.uniprot.org/uniprotkb/Q6PI48/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DARS2","classification":"Not Classified","n_dependent_lines":344,"n_total_lines":1208,"dependency_fraction":0.2847682119205298},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DARS2","total_profiled":1310},"omim":[{"mim_id":"621485","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2LL; CMT2LL","url":"https://www.omim.org/entry/621485"},{"mim_id":"619147","title":"LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID","url":"https://www.omim.org/entry/619147"},{"mim_id":"616370","title":"MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4","url":"https://www.omim.org/entry/616370"},{"mim_id":"615281","title":"HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL","url":"https://www.omim.org/entry/615281"},{"mim_id":"611105","title":"LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL","url":"https://www.omim.org/entry/611105"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DARS2"},"hgnc":{"alias_symbol":["FLJ10514","mtAspRS"],"prev_symbol":[]},"alphafold":{"accession":"Q6PI48","domains":[{"cath_id":"2.40.50.140","chopping":"60-151","consensus_level":"high","plddt":94.824,"start":60,"end":151},{"cath_id":"3.30.930.10","chopping":"187-319_479-601","consensus_level":"medium","plddt":95.4654,"start":187,"end":601},{"cath_id":"3.30.1360.30","chopping":"338-467","consensus_level":"high","plddt":89.2445,"start":338,"end":467}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6PI48","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6PI48-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6PI48-F1-predicted_aligned_error_v6.png","plddt_mean":89.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DARS2","jax_strain_url":"https://www.jax.org/strain/search?query=DARS2"},"sequence":{"accession":"Q6PI48","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6PI48.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6PI48/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6PI48"}},"corpus_meta":[{"pmid":"24606902","id":"PMC_24606902","title":"Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24606902","citation_count":189,"is_preprint":false},{"pmid":"25378325","id":"PMC_25378325","title":"Timely binding of IHF and Fis to DARS2 regulates ATP-DnaA production and replication initiation.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25378325","citation_count":61,"is_preprint":false},{"pmid":"29052520","id":"PMC_29052520","title":"Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.","date":"2017","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/29052520","citation_count":60,"is_preprint":false},{"pmid":"19592391","id":"PMC_19592391","title":"DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19592391","citation_count":59,"is_preprint":false},{"pmid":"22023289","id":"PMC_22023289","title":"Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell-type-dependent splicing of mtAspRS mRNA.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22023289","citation_count":41,"is_preprint":false},{"pmid":"21749991","id":"PMC_21749991","title":"Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21749991","citation_count":39,"is_preprint":false},{"pmid":"28985337","id":"PMC_28985337","title":"DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28985337","citation_count":35,"is_preprint":false},{"pmid":"22677571","id":"PMC_22677571","title":"Neuropathology of leukoencephalopathy with brainstem and spinal cord involvement and high lactate caused by a homozygous mutation of DARS2.","date":"2012","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/22677571","citation_count":32,"is_preprint":false},{"pmid":"21792730","id":"PMC_21792730","title":"Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene.","date":"2011","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21792730","citation_count":26,"is_preprint":false},{"pmid":"20501884","id":"PMC_20501884","title":"Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene.","date":"2010","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20501884","citation_count":25,"is_preprint":false},{"pmid":"27452301","id":"PMC_27452301","title":"Chromosomal location of the DnaA-reactivating sequence DARS2 is important to regulate timely initiation of DNA replication in Escherichia coli.","date":"2016","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/27452301","citation_count":22,"is_preprint":false},{"pmid":"32766765","id":"PMC_32766765","title":"DARS2 is indispensable for Purkinje cell survival and protects against cerebellar ataxia.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32766765","citation_count":19,"is_preprint":false},{"pmid":"33977142","id":"PMC_33977142","title":"LBSL: Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations.","date":"2021","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33977142","citation_count":17,"is_preprint":false},{"pmid":"31887305","id":"PMC_31887305","title":"Neuronal ablation of mt-AspRS in mice induces immune pathway activation prior to severe and progressive cortical and behavioral disruption.","date":"2019","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31887305","citation_count":17,"is_preprint":false},{"pmid":"23652419","id":"PMC_23652419","title":"Impaired information-processing speed and working memory in leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate (LBSL) and DARS2 mutations: a report of three adult patients.","date":"2013","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23652419","citation_count":15,"is_preprint":false},{"pmid":"26327357","id":"PMC_26327357","title":"Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene.","date":"2015","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/26327357","citation_count":14,"is_preprint":false},{"pmid":"39990673","id":"PMC_39990673","title":"DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39990673","citation_count":13,"is_preprint":false},{"pmid":"34871419","id":"PMC_34871419","title":"Negative feedback for DARS2-Fis complex by ATP-DnaA supports the cell cycle-coordinated regulation for chromosome replication.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34871419","citation_count":13,"is_preprint":false},{"pmid":"30352563","id":"PMC_30352563","title":"Intra-familial phenotypic heterogeneity in a Sudanese family with DARS2-related leukoencephalopathy, brainstem and spinal cord involvement and lactate elevation: a case report.","date":"2018","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30352563","citation_count":13,"is_preprint":false},{"pmid":"37563224","id":"PMC_37563224","title":"Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37563224","citation_count":11,"is_preprint":false},{"pmid":"37626419","id":"PMC_37626419","title":"DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37626419","citation_count":8,"is_preprint":false},{"pmid":"34631948","id":"PMC_34631948","title":"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation: A Novel DARS2 Mutation and Intra-Familial Heterogeneity.","date":"2021","source":"Movement disorders clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/34631948","citation_count":8,"is_preprint":false},{"pmid":"36182716","id":"PMC_36182716","title":"New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin.","date":"2022","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/36182716","citation_count":7,"is_preprint":false},{"pmid":"30635318","id":"PMC_30635318","title":"Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene.","date":"2019","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/30635318","citation_count":7,"is_preprint":false},{"pmid":"37950542","id":"PMC_37950542","title":"DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.","date":"2023","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37950542","citation_count":6,"is_preprint":false},{"pmid":"34104671","id":"PMC_34104671","title":"Perinatal Manifestations of DARS2-Associated Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL).","date":"2021","source":"Child neurology open","url":"https://pubmed.ncbi.nlm.nih.gov/34104671","citation_count":6,"is_preprint":false},{"pmid":"32308605","id":"PMC_32308605","title":"A New DARS2 Mutation Discovered in an Adult Patient.","date":"2020","source":"Case reports in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32308605","citation_count":5,"is_preprint":false},{"pmid":"38361754","id":"PMC_38361754","title":"MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.","date":"2024","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/38361754","citation_count":4,"is_preprint":false},{"pmid":"29138691","id":"PMC_29138691","title":"A novel DARS2 mutation in a Japanese patient with leukoencephalopathy with brainstem and spinal cord involvement but no lactate elevation.","date":"2017","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/29138691","citation_count":3,"is_preprint":false},{"pmid":"39417889","id":"PMC_39417889","title":"Role of spexin and DARS2 as potential biomarkers in basal cell carcinoma and cutaneous malignant melanoma diagnosis, and as therapeutic targets.","date":"2024","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/39417889","citation_count":3,"is_preprint":false},{"pmid":"38125072","id":"PMC_38125072","title":"Leukoencephalopathy with Brain stem and Spinal cord involvement and Lactate elevation (LBSL): Report of a new family and a novel DARS2 mutation.","date":"2023","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/38125072","citation_count":2,"is_preprint":false},{"pmid":"38382106","id":"PMC_38382106","title":"Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.","date":"2024","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/38382106","citation_count":2,"is_preprint":false},{"pmid":"35820270","id":"PMC_35820270","title":"Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.","date":"2022","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35820270","citation_count":2,"is_preprint":false},{"pmid":"36909591","id":"PMC_36909591","title":"Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/36909591","citation_count":1,"is_preprint":false},{"pmid":"40185339","id":"PMC_40185339","title":"Aminolevulinate/iron exposure elicited Nrf-2-mediated cytoprotection in DARS2 deficient fibroblasts with impaired energy and antioxidant metabolisms.","date":"2025","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40185339","citation_count":1,"is_preprint":false},{"pmid":"41214844","id":"PMC_41214844","title":"Secreted mitochondrial aspartyl-tRNA synthetase (DARS2) regulates TNFα signaling.","date":"2025","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/41214844","citation_count":1,"is_preprint":false},{"pmid":"39797733","id":"PMC_39797733","title":"Negative DNA supercoiling enhances DARS2 binding of DNA-bending protein IHF in the activation of Fis-dependent ATP-DnaA production.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39797733","citation_count":1,"is_preprint":false},{"pmid":"38790244","id":"PMC_38790244","title":"Identification of a Novel Indel Variant in the DARS2 Gene in Russian Patients with Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation.","date":"2024","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/38790244","citation_count":1,"is_preprint":false},{"pmid":"40814755","id":"PMC_40814755","title":"Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot-Marie-Tooth Disease.","date":"2025","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40814755","citation_count":0,"is_preprint":false},{"pmid":"38825905","id":"PMC_38825905","title":"[Expression of DARS2 in colorectal cancer and its clinical significance].","date":"2024","source":"Zhonghua bing li xue za zhi = Chinese journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/38825905","citation_count":0,"is_preprint":false},{"pmid":"41364147","id":"PMC_41364147","title":"Integrated multi-omics analysis identifies DARS2, MRTO4, and MRPL37 as novel biomarkers and potential therapeutic targets for bladder cancer.","date":"2025","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41364147","citation_count":0,"is_preprint":false},{"pmid":"41859393","id":"PMC_41859393","title":"Aging Inhibits Emergency Angiogenesis and Exacerbates Neuronal Damage by Downregulating DARS2.","date":"2026","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/41859393","citation_count":0,"is_preprint":false},{"pmid":"40948401","id":"PMC_40948401","title":"AAV9-DARS2 Gene Therapy Rescues Phenotype in Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation Patient Cells and Neuronal Dars2 Deficient Mice.","date":"2025","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40948401","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22743,"output_tokens":3421,"usd":0.059772},"stage2":{"model":"claude-opus-4-6","input_tokens":6804,"output_tokens":3113,"usd":0.167768},"total_usd":0.22754,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"DARS2 (mitochondrial aspartyl-tRNA synthetase) is required for mitochondrial protein synthesis; its loss in heart and skeletal muscle leads to severe respiratory chain deficiency, but stress responses (including FGF21 mitokine induction) are activated in a tissue-specific manner in cardiomyocytes independently of respiratory chain deficiency, demonstrating that mitochondrial proteostasis impairment is sensed as a distinct signal.\",\n      \"method\": \"Conditional cardiac/skeletal muscle Dars2 knockout mice; respiratory chain complex assays; FGF21 expression analysis; mitochondrial protein synthesis measurements\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean tissue-specific KO with multiple orthogonal readouts (RC assays, protein synthesis, FGF21 signaling), replicated across two tissues\",\n      \"pmids\": [\"24606902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cell-type-specific splicing of DARS2 mRNA determines vulnerability in LBSL: intronic mutations affecting exon 3 splicing have a larger effect on exon 3 exclusion in neural (especially neuronal) cell lines than in non-neural cells, and baseline inclusion of exon 3 is less efficient in neural cells, explaining selective white matter tract involvement.\",\n      \"method\": \"Splicing reporter construct transfected into neural vs. non-neural cell lines; quantitative RT-PCR of exon inclusion\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional splicing reporter assay across multiple cell types with clear mechanistic outcome\",\n      \"pmids\": [\"22023289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Loss of DARS2 in forebrain-hippocampal neurons causes strong mitochondrial dysfunction and progressive neuronal cell death, whereas myelin-producing cells are resistant to cell death despite robust respiratory chain deficiency, indicating that neuronal/axonal loss is the primary defect in LBSL; neuroinflammation is activated early in disease progression.\",\n      \"method\": \"Conditional Dars2 knockout in forebrain neurons (CamKII-Cre) and oligodendrocytes; respiratory chain assays; histopathology; immunostaining for neuroinflammation markers\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with defined cellular phenotype and mechanistic distinction between cell types\",\n      \"pmids\": [\"28985337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DARS2 is indispensable for Purkinje cell survival; conditional Purkinje cell-specific Dars2 deletion causes severe mitochondrial dysfunction, massive Purkinje cell loss by 15 weeks, rapid motor skill deterioration, and prominent neuroinflammation.\",\n      \"method\": \"Purkinje cell-specific conditional Dars2 knockout mice (Pcp2-Cre); mitochondrial function assays; histopathology; behavioral motor testing; immunostaining for neuroinflammation\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with multiple functional and histological readouts\",\n      \"pmids\": [\"32766765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dars2 disruption in CamKIIα-expressing cortical and hippocampal neurons leads to progressive brain atrophy, reduced corpus callosum thickness, behavioral dysfunction, and microglial neuroinflammation; RNA-seq shows immune/cytokine pathway activation precedes the overt behavioral phenotype.\",\n      \"method\": \"CamKIIα-Cre conditional Dars2 knockout mice; RNAseq gene expression; behavioral assays; MRI; microglial morphology analysis\",\n      \"journal\": \"Experimental Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with transcriptomic and behavioral/histological phenotyping across timepoints\",\n      \"pmids\": [\"31887305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DARS2 encodes a mitochondrial aspartyl-tRNA synthetase homodimer; missense variants that hit regions involved in tRNA-Asp binding, aspartyl-adenosine-5'-monophosphate binding, and/or homodimerization abolish mitochondrial function when expressed in the yeast DARS2 ortholog (MSD1), establishing structure-function relationships for catalytic and dimerization domains.\",\n      \"method\": \"Structural analysis of variant positions; functional complementation in msd1Δ yeast (oxidative growth assay)\",\n      \"journal\": \"Neurology. Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast functional complementation plus structural analysis, single study\",\n      \"pmids\": [\"33977142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Specific DARS2 missense variants (p.Glu158Val; p.Glu277Lys) differentially impair mitochondrial aspartyl-tRNA synthetase function: p.Glu277Lys (equivalent to yeast p.Glu259Lys) causes complete loss of oxidative growth and oxygen consumption, while p.Glu158Val (equivalent to yeast p.Gln137Val) causes significant but partial loss; structural analysis indicates p.Glu158Val interferes with tRNA-Asp binding and p.Glu277Lys impacts homodimerization and catalysis.\",\n      \"method\": \"Yeast msd1Δ complementation assay (oxidative growth, oxygen consumption); in silico structural modeling\",\n      \"journal\": \"Molecular Genetics and Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional yeast assay with multiple variants and structural analysis, single lab\",\n      \"pmids\": [\"35820270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DARS2 promotes bladder cancer cell cycle progression (G1-to-S transition) by upregulating CDK4 expression, suppressing cellular senescence, and enhancing PINK1-mediated mitophagy; both in vitro and in vivo experiments confirmed DARS2 inhibits senescence and drives tumor progression through this mitophagy pathway.\",\n      \"method\": \"siRNA knockdown and overexpression in bladder cancer cells; xenograft mouse models; flow cytometry cell cycle analysis; CDK4/PINK1 Western blot; mitophagy assays\",\n      \"journal\": \"International Journal of Biological Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO/OE with defined molecular pathway (CDK4, PINK1-mitophagy) validated in vitro and in vivo, single lab\",\n      \"pmids\": [\"39990673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DARS2 mutations in LBSL patient iPSC-derived cerebral organoids cause global dysregulation of mRNA metabolism and splicing, including dysregulated RNA splicing and protein translation pathways; DARS2 protein is downregulated in iPSC-derived neurons due to increased exon 3 exclusion, and LBSL neurons show growth defects under live cell imaging, suggesting DARS2 may have roles beyond canonical aminoacylation.\",\n      \"method\": \"SMART-seq2 single-cell RNA sequencing of patient iPSC-derived cerebral organoids; iPSC-derived neurons via Neurogenin 2 overexpression; live cell imaging of neuronal growth; exon 3 splicing analysis; Western blot for DARS2 protein\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-modal analysis in patient-derived organoids and neurons, single lab with orthogonal methods\",\n      \"pmids\": [\"37563224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DARS2 is secreted from airway epithelial cells in response to TNFα stimulation in a TNF-receptor 1-dependent manner via the endosomal sorting complex required for extracellular transport; secreted DARS2 binds to macrophages, is internalized, and induces an M1-like phenotype in recipient macrophages, establishing a paracrine cytokine-modulatory role for mitochondrial DARS2.\",\n      \"method\": \"BEAS-2B cell secretion assays; adoptive media transfer to THP1 macrophages; blocking antibodies against TNFR1; siRNA knockdown; chemical inhibitors of endosomal sorting; macrophage polarization readouts\",\n      \"journal\": \"Physiological Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic secretion and paracrine signaling study with multiple inhibitor approaches, single lab\",\n      \"pmids\": [\"41214844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A p.Pro503Leu DARS2 variant reduces enzymatic (aminoacylation) activity by 75% in HEK293 cells; hypomorphic variant p.Ser238Phe paired with more deleterious alleles results in axonal CMT without leukoencephalopathy, establishing a genotype-severity continuum for DARS2-associated diseases; functional studies in fibroblasts showed reduced DARS2 protein, mitochondrial network abnormalities, and impaired mitochondrial function.\",\n      \"method\": \"Enzymatic activity assay in HEK293 cells; fibroblast functional studies (DARS2 protein levels, mitochondrial network imaging, mitochondrial function assays)\",\n      \"journal\": \"Annals of Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct enzymatic activity assay plus fibroblast functional studies, multiple variants and families\",\n      \"pmids\": [\"40814755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AAV9-mediated DARS2 gene supplementation in LBSL patient iPSC-derived neurons increases DARS2 expression, improves mitochondrial function, promotes axonal growth, and reduces lactate release; in CamKIIα-Cre Dars2 knockout mice, intracerebroventricular AAV9-DARS2 injection improves behavior and reduces cortical neurodegeneration at 6 months, providing proof-of-concept for gene therapy.\",\n      \"method\": \"AAV9 gene delivery in patient iPSC-derived neurons (mitochondrial function, axonal growth, lactate assays); intracerebroventricular injection in Dars2 conditional KO mice (behavioral testing, histopathology)\",\n      \"journal\": \"Annals of Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gene rescue in both patient cell model and mouse KO, multiple functional readouts, single study\",\n      \"pmids\": [\"40948401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ALA/Fe (aminolevulinate plus ferrous iron) treatment rescues marked mitochondrial and antioxidant deficiencies in DARS2-deficient fibroblasts from LBSL patients via Nrf-2-mediated cytoprotection; dexamethasone (Nrf-2 inhibitor) blocks these positive effects, identifying Nrf-2 pathway activation as a therapeutic mechanism.\",\n      \"method\": \"LBSL patient fibroblasts treated with ALA/Fe; mitochondrial function and antioxidant assays; Nrf-2 pathway inhibition with dexamethasone\",\n      \"journal\": \"Biochimica et Biophysica Acta. Molecular Basis of Disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological rescue in patient fibroblasts, single lab, mechanistic link inferred from inhibitor experiment\",\n      \"pmids\": [\"40185339\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DARS2 encodes mitochondrial aspartyl-tRNA synthetase, a homodimeric enzyme that catalyzes the aminoacylation of mitochondrial tRNA-Asp (required for mitochondrial protein synthesis); loss of DARS2 impairs mitochondrial translation and respiratory chain function in a tissue- and cell-type-specific manner, with neurons (especially Purkinje cells and cortical neurons) being particularly vulnerable to DARS2 depletion-induced mitochondrial dysfunction and death while oligodendrocytes are relatively resistant, and DARS2 additionally functions outside mitochondria as a TNFα-inducible secreted factor that modulates macrophage polarization, and within cancer cells promotes cell cycle progression via CDK4 and PINK1-mediated mitophagy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DARS2 encodes the mitochondrial aspartyl-tRNA synthetase, a homodimeric enzyme that aminoacylates mitochondrial tRNA-Asp and is therefore essential for mitochondrial translation and respiratory chain function [PMID:24606902, PMID:33977142]. Loss of DARS2 causes severe, cell-type-specific vulnerability: neurons—particularly Purkinje cells and cortical/hippocampal neurons—undergo progressive mitochondrial dysfunction, neuroinflammation, and cell death, whereas oligodendrocytes tolerate respiratory chain deficiency, explaining the predominantly neuronal pathology in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a disease caused by biallelic DARS2 mutations whose severity follows a genotype-dependent continuum extending to axonal Charcot-Marie-Tooth neuropathy [PMID:28985337, PMID:32766765, PMID:22023289, PMID:40814755]. Cell-type-specific differences in DARS2 exon 3 splicing efficiency govern the degree of residual functional protein in neural versus non-neural cells, providing a molecular basis for selective CNS vulnerability [PMID:22023289, PMID:37563224]. Beyond its canonical mitochondrial aminoacylation role, DARS2 is secreted from epithelial cells in a TNFα/TNFR1-dependent manner and promotes M1-like macrophage polarization, and in cancer cells it drives G1-to-S cell cycle progression via CDK4 upregulation and PINK1-mediated mitophagy [PMID:41214844, PMID:39990673].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolving why DARS2 mutations selectively damage the nervous system despite ubiquitous expression, this study showed that cell-type-specific splicing efficiency of DARS2 exon 3 is intrinsically lower in neural cells, so intronic LBSL mutations cause disproportionate exon skipping and protein loss in the most vulnerable tissue.\",\n      \"evidence\": \"Splicing reporter constructs transfected into neural vs. non-neural cell lines with quantitative RT-PCR readout\",\n      \"pmids\": [\"22023289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Trans-acting splicing factors responsible for differential exon 3 inclusion are not identified\",\n        \"Splicing was measured in cell lines, not primary human neurons or oligodendrocytes in vivo\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing the core enzymatic requirement, conditional Dars2 knockout in heart and skeletal muscle demonstrated that DARS2 is essential for mitochondrial protein synthesis and respiratory chain assembly, and revealed that mitochondrial proteostasis stress signals (e.g., FGF21 induction) are activated independently of respiratory chain deficiency.\",\n      \"evidence\": \"Conditional cardiac/skeletal muscle Dars2 knockout mice with respiratory chain assays, mitochondrial translation measurements, and FGF21 expression analysis\",\n      \"pmids\": [\"24606902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the same proteostasis stress responses occur in neurons was not tested\",\n        \"Downstream signaling pathways connecting mitochondrial proteostasis sensing to FGF21 induction were not fully delineated\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that neuronal death—not demyelination—is the primary driver of LBSL pathology, cell-type-specific Dars2 ablation showed that forebrain neurons die progressively from mitochondrial dysfunction while oligodendrocytes survive despite equivalent respiratory chain deficiency.\",\n      \"evidence\": \"CamKII-Cre and oligodendrocyte-Cre conditional Dars2 knockout mice with respiratory chain assays, histopathology, and neuroinflammation markers\",\n      \"pmids\": [\"28985337\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis for oligodendrocyte resistance to DARS2 loss remains unknown\",\n        \"Whether secondary demyelination contributes to disease progression independently of neuronal loss is unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extending the neuronal phenotype, Dars2 loss in cortical and hippocampal neurons was shown to cause progressive brain atrophy, corpus callosum thinning, and behavioral deficits, with transcriptomic evidence that microglial neuroinflammation precedes overt neurodegeneration.\",\n      \"evidence\": \"CamKIIα-Cre conditional Dars2 knockout mice with RNA-seq, behavioral assays, MRI, and microglial morphology analysis\",\n      \"pmids\": [\"31887305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Causal contribution of neuroinflammation versus intrinsic neuronal death to disease progression not dissected\",\n        \"Whether anti-inflammatory intervention can slow neurodegeneration was not tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Purkinje cells were shown to be exquisitely dependent on DARS2, with cell-specific deletion causing near-complete Purkinje cell loss by 15 weeks and rapid cerebellar ataxia, consistent with the prominent cerebellar phenotype in LBSL patients.\",\n      \"evidence\": \"Pcp2-Cre Purkinje cell-specific Dars2 knockout mice with mitochondrial function assays, histopathology, and motor behavioral testing\",\n      \"pmids\": [\"32766765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Purkinje cell vulnerability reflects higher mitochondrial translation demand or lower compensatory capacity is unresolved\",\n        \"Non-cell-autonomous effects on other cerebellar neurons not characterized\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Structure–function relationships were established for DARS2: the enzyme functions as a homodimer, and missense variants disrupting tRNA-Asp binding, aminoacyl-adenylate binding, or the dimerization interface abolish mitochondrial function.\",\n      \"evidence\": \"Structural analysis of variant positions with functional complementation in yeast msd1Δ (oxidative growth assay)\",\n      \"pmids\": [\"33977142\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No crystal structure of human DARS2 is available; structural inferences are based on homology models\",\n        \"Aminoacylation kinetics for individual variants not measured in a purified system\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genotype–severity correlations were refined: the p.Glu277Lys variant (affecting dimerization/catalysis) completely ablates function whereas p.Glu158Val (affecting tRNA binding) causes partial loss, demonstrating that different domains contribute unequally to catalytic activity.\",\n      \"evidence\": \"Yeast msd1Δ complementation with oxidative growth and oxygen consumption measurements plus in silico structural modeling\",\n      \"pmids\": [\"35820270\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Human DARS2 enzymatic activity for these variants not measured directly\",\n        \"Whether partial loss variants permit residual mitochondrial translation in human neurons is untested\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Patient iPSC-derived cerebral organoids revealed that DARS2 deficiency causes broad mRNA metabolism and splicing dysregulation beyond simple aminoacylation loss, with LBSL neurons showing growth defects, suggesting non-canonical DARS2 roles.\",\n      \"evidence\": \"SMART-seq2 single-cell RNA-seq of LBSL patient iPSC-derived organoids; live cell imaging of iPSC-derived neurons; exon 3 splicing and protein analysis\",\n      \"pmids\": [\"37563224\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether RNA metabolism changes are direct or secondary to mitochondrial dysfunction is unresolved\",\n        \"Non-canonical DARS2 functions have not been biochemically defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Multiple independent advances in 2025 expanded DARS2 biology in three directions: (1) a genotype-severity continuum was demonstrated, with hypomorphic variants causing axonal CMT without leukoencephalopathy; (2) AAV9-mediated DARS2 gene supplementation rescued neuronal mitochondrial function and neurodegeneration in both patient cells and knockout mice; and (3) DARS2 was found to have extramitochondrial functions—as a TNFα-induced secreted factor driving M1 macrophage polarization and as a bladder cancer cell cycle promoter via CDK4/PINK1-mitophagy.\",\n      \"evidence\": \"Enzymatic activity assays in HEK293 cells and patient fibroblasts (PMID:40814755); AAV9 gene delivery in iPSC neurons and intracerebroventricular injection in Dars2 KO mice (PMID:40948401); airway epithelial cell secretion assays with macrophage polarization readouts (PMID:41214844); siRNA/overexpression in bladder cancer cells with xenograft validation (PMID:39990673)\",\n      \"pmids\": [\"40814755\", \"40948401\", \"41214844\", \"39990673\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"AAV9 gene therapy long-term efficacy and optimal dosing not established\",\n        \"Mechanism by which DARS2 exits mitochondria for secretion is not defined\",\n        \"CDK4/PINK1-mitophagy link to DARS2 in cancer awaits independent replication\",\n        \"Whether the secreted DARS2 paracrine function is relevant in the CNS is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular basis for differential neuronal versus glial vulnerability to DARS2 loss, whether non-canonical (extra-mitochondrial) DARS2 functions contribute to LBSL pathogenesis, and whether gene therapy can achieve durable clinical benefit in patients.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of human DARS2 is available\",\n        \"Direct aminoacylation kinetics for disease-associated variants have not been measured with purified human enzyme\",\n        \"Mechanism connecting DARS2 loss to the mRNA splicing dysregulation observed in organoids is unknown\",\n        \"Contribution of neuroinflammation as a therapeutic target in LBSL is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 5, 6, 10]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 6, 10]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 3, 5]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 5, 6, 10]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2, 3, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\n      \"DARS2 homodimer\"\n    ],\n    \"partners\": [\n      \"CDK4\",\n      \"PINK1\",\n      \"TNFRSF1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}